share_log

B of A Securities Upgrades Revolution Medicines to Buy, Announces $34 Price Target

B of A Securities Upgrades Revolution Medicines to Buy, Announces $34 Price Target

B of A 证券将Revolution Medicines上调至买入,宣布目标股价为34美元
Benzinga ·  01/05 08:02

B of A Securities analyst Alec Stranahan upgrades Revolution Medicines (NASDAQ:RVMD) from Neutral to Buy and announces $34 price target.

B of A Securities分析师亚历克·斯特拉纳汉将Revolution Medicines(纳斯达克股票代码:RVMD)从中性上调至买入,并宣布了34美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发